Daria A. Gerasimova
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Biomarkers of treatment response in rheumatoid arthritis: from conventional markers to tissue immunophenotype.
Journal: Frontiers in immunology
Published: May 13, 2026
Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on "Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425".
Journal: International journal of molecular sciences
Published: February 17, 2025
Dynamics of Modified Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis on the Background of 5-Year Therapy with an Interleukin 6 Receptor Inhibitor.
Journal: Doklady. Biochemistry and biophysics
Published: February 02, 2025
Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis.
Journal: International journal of molecular sciences
Published: October 09, 2024
Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis.
Journal: Frontiers in bioscience (Landmark edition)
Published: May 20, 2024
Systemic Sclerosis and Atherosclerosis: Potential Cellular Biomarkers and Mechanisms.
Journal: Frontiers in bioscience (Scholar edition)
Published: October 22, 2023
Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases.
Journal: International journal of molecular sciences
Published: June 05, 2022
Macrophage Dysfunction in Autoimmune Rheumatic Diseases and Atherosclerosis.
Journal: International journal of molecular sciences
Published: March 16, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026